Government to back two companies’ drug development

Published: 2012-08-10 06:57:00

Updated: 2012-08-10 06:57:00

Daewoong Pharmaceutical plans to develop a combination drug for treatment of cardiovascular disease, and HanAll Biopharma will also carry out clinical trials for its sustained-release pulmonary hypertension drug with low molecular weight as part of a government program to cultivate blockbuster dr...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK